198 related articles for article (PubMed ID: 22349714)
1. A novel improved therapy strategy for diabetic nephropathy: targeting AGEs.
Zhou X; Wang B; Zhu L; Hao S
Organogenesis; 2012; 8(1):18-21. PubMed ID: 22349714
[TBL] [Abstract][Full Text] [Related]
2. AGE-RAGE axis blockade in diabetic nephropathy: Current status and future directions.
Sanajou D; Ghorbani Haghjo A; Argani H; Aslani S
Eur J Pharmacol; 2018 Aug; 833():158-164. PubMed ID: 29883668
[TBL] [Abstract][Full Text] [Related]
3. Salvianolic Acid A Protects Against Diabetic Nephropathy through Ameliorating Glomerular Endothelial Dysfunction via Inhibiting AGE-RAGE Signaling.
Hou B; Qiang G; Zhao Y; Yang X; Chen X; Yan Y; Wang X; Liu C; Zhang L; Du G
Cell Physiol Biochem; 2017; 44(6):2378-2394. PubMed ID: 29262395
[TBL] [Abstract][Full Text] [Related]
4. Advanced glycation end products (AGEs) increase renal lipid accumulation: a pathogenic factor of diabetic nephropathy (DN).
Yuan Y; Sun H; Sun Z
Lipids Health Dis; 2017 Jun; 16(1):126. PubMed ID: 28659153
[TBL] [Abstract][Full Text] [Related]
5. An integrated network pharmacology and transcriptomic method to explore the mechanism of the total Rhizoma Coptidis alkaloids in improving diabetic nephropathy.
Xiao Y; Liu Y; Lai Z; Huang J; Li C; Zhang Y; Gong X; Deng J; Ye X; Li X
J Ethnopharmacol; 2021 Apr; 270():113806. PubMed ID: 33444721
[TBL] [Abstract][Full Text] [Related]
6. Grape seed proanthocyanidins ameliorate diabetic nephropathy via modulation of levels of AGE, RAGE and CTGF.
Li X; Xiao Y; Gao H; Li B; Xu L; Cheng M; Jiang B; Ma Y
Nephron Exp Nephrol; 2009; 111(2):e31-41. PubMed ID: 19142024
[TBL] [Abstract][Full Text] [Related]
7. Relationship between the expression of advanced glycation end-products (AGE) and the receptor for AGE (RAGE) mRNA in diabetic nephropathy.
Suzuki D; Toyoda M; Yamamoto N; Miyauchi M; Katoh M; Kimura M; Maruyama M; Honma M; Umezono T; Yagame M
Intern Med; 2006; 45(7):435-41. PubMed ID: 16679697
[TBL] [Abstract][Full Text] [Related]
8. AKF-PD alleviates diabetic nephropathy via blocking the RAGE/AGEs/NOX and PKC/NOX Pathways.
Qin J; Peng Z; Yuan Q; Li Q; Peng Y; Wen R; Hu Z; Liu J; Xia X; Deng H; Xiong X; Hu J; Tao L
Sci Rep; 2019 Mar; 9(1):4407. PubMed ID: 30867431
[TBL] [Abstract][Full Text] [Related]
9. The anti-inflammation effect of Moutan Cortex on advanced glycation end products-induced rat mesangial cells dysfunction and High-glucose-fat diet and streptozotocin-induced diabetic nephropathy rats.
Zhang MH; Feng L; Zhu MM; Gu JF; Jiang J; Cheng XD; Ding SM; Wu C; Jia XB
J Ethnopharmacol; 2014; 151(1):591-600. PubMed ID: 24269777
[TBL] [Abstract][Full Text] [Related]
10. Receptor for advanced glycation end products (RAGE): a novel therapeutic target for diabetic vascular complication.
Yamagishi S; Nakamura K; Matsui T; Noda Y; Imaizumi T
Curr Pharm Des; 2008; 14(5):487-95. PubMed ID: 18289075
[TBL] [Abstract][Full Text] [Related]
11. A Perspective on the Impact of Advanced Glycation End Products in the Progression of Diabetic Nephropathy.
Khanam A; Ahmad S; Husain A
Curr Protein Pept Sci; 2023; 24(1):2-6. PubMed ID: 36366848
[TBL] [Abstract][Full Text] [Related]
12. Radix Rehmanniae and Corni Fructus against Diabetic Nephropathy via AGE-RAGE Signaling Pathway.
Chen J; Chen Y; Shu A; Lu J; Du Q; Yang Y; Lv Z; Xu H
J Diabetes Res; 2020; 2020():8358102. PubMed ID: 33344651
[TBL] [Abstract][Full Text] [Related]
13. Autophagy-Lysosome Pathway in Renal Tubular Epithelial Cells Is Disrupted by Advanced Glycation End Products in Diabetic Nephropathy.
Liu WJ; Shen TT; Chen RH; Wu HL; Wang YJ; Deng JK; Chen QH; Pan Q; Huang Fu CM; Tao JL; Liang D; Liu HF
J Biol Chem; 2015 Aug; 290(33):20499-510. PubMed ID: 26100632
[TBL] [Abstract][Full Text] [Related]
14. Advanced glycation end products mediated cellular and molecular events in the pathology of diabetic nephropathy.
Kumar Pasupulati A; Chitra PS; Reddy GB
Biomol Concepts; 2016 Dec; 7(5-6):293-309. PubMed ID: 27816946
[TBL] [Abstract][Full Text] [Related]
15. Flavonoids derived from buckwheat hull can break advanced glycation end-products and improve diabetic nephropathy.
Li T; Yang Y; Wang X; Dai W; Zhang L; Piao C
Food Funct; 2021 Aug; 12(16):7161-7170. PubMed ID: 34169956
[TBL] [Abstract][Full Text] [Related]
16. Contribution of myo-inositol oxygenase in AGE:RAGE-mediated renal tubulointerstitial injury in the context of diabetic nephropathy.
Sharma I; Tupe RS; Wallner AK; Kanwar YS
Am J Physiol Renal Physiol; 2018 Jan; 314(1):F107-F121. PubMed ID: 28931523
[TBL] [Abstract][Full Text] [Related]
17. [Extract of Ginkgo biloba and alpha-lipoic acid attenuate advanced glycation end products accumulation and RAGE expression in diabetic nephropathy rats].
Li XZ; Yan HD; Wang J
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 Apr; 31(4):525-31. PubMed ID: 21608227
[TBL] [Abstract][Full Text] [Related]
18. Catalpol ameliorates endothelial dysfunction and inflammation in diabetic nephropathy via suppression of RAGE/RhoA/ROCK signaling pathway.
Shu A; Du Q; Chen J; Gao Y; Zhu Y; Lv G; Lu J; Chen Y; Xu H
Chem Biol Interact; 2021 Oct; 348():109625. PubMed ID: 34416245
[TBL] [Abstract][Full Text] [Related]
19. RAGE in diabetic nephropathy.
Yamamoto H; Watanabe T; Yamamoto Y; Yonekura H; Munesue S; Harashima A; Ooe K; Hossain S; Saito H; Murakami N
Curr Mol Med; 2007 Dec; 7(8):752-7. PubMed ID: 18331233
[TBL] [Abstract][Full Text] [Related]
20. Hesperetin ameliorates diabetic nephropathy in rats by activating Nrf2/ARE/glyoxalase 1 pathway.
Chen YJ; Kong L; Tang ZZ; Zhang YM; Liu Y; Wang TY; Liu YW
Biomed Pharmacother; 2019 Mar; 111():1166-1175. PubMed ID: 30841430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
